Deborah Andrews's most recent trade in Staar Surgical Co. was a trade of 10,466 Common Stock done . Disclosure was reported to the exchange on May 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Staar Surgical Co. | Deborah Andrews | Interim Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 10,466 | 10,466 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Deborah Andrews | Interim Co-CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 10,466 | 10,466 | - | - | Performance Stock Units | |
| Staar Surgical Co. | Deborah Andrews | Interim Co-CEO and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 5,233 | 15,699 | - | - | Performance Stock Units | |
| Staar Surgical Co. | Deborah Andrews | Interim Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 5,233 | 20,530 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Deborah Andrews | Interim Co-CEO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 3,755 | 15,297 (0%) | 0% | 32.1 | 120,423 | Common Stock |
| Staar Surgical Co. | Deborah Andrews | Interim Co-CEO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.07 per share. | 15 May 2026 | 1,877 | 18,653 (0%) | 0% | 32.1 | 60,195 | Common Stock |
| Staar Surgical Co. | Deborah Andrews | Interim Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 39,809 | 39,809 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Deborah Andrews | Interim Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 20,787 | 20,787 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Deborah Andrews | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 41,867 | 41,867 | - | - | Restricted Stock Units |